title: Bilateral de quervain syndrome after aromatase inhibitor administration: a case report and review of the literature.
abstract: Aromatase inhibitors are widely used as one of the main treatment options of both early and advanced hormone receptor-positive breast cancer in postmenopausal women. Unfortunately, musculoskeletal symptoms are often presented in patients treated with aromatase inhibitors (AIs), and, although the pathogenesis is unknown, postulated mechanisms have been described. Herein, to our knowledge, we present the first report of bilateral De Quervain syndrome related with AIs therapy with a review of the relevant literature.
authors.affiliation: Department of Medical Oncology, BOC Oncology Centre, Nicosia, 2006 Strovolos, Cyprus.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Papadimitriou
authors.forename: Panteleimon
authors.initials: P
authors.lastname: Kountourakis
authors.forename: Emmanouil
authors.initials: E
authors.lastname: Morakis
authors.forename: Vassilios
authors.initials: V
authors.lastname: Vassiliou
authors.forename: Vasileios
authors.initials: V
authors.lastname: Barbounis
authors.forename: Alexandros
authors.initials: A
authors.lastname: Ardavanis